Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

174 та иш

Иш: A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes

  1. Regulation of colon cancer recurrence and development of therapeutic strategies

    Shailender S. Kanwar

    Мақола20122 иқтибос
    ABI
  2. Acute and 13 weeks subchronic toxicological evaluation of naringin in Sprague-Dawley rats

    Peibo Li, Sheng Wang, Xiaolin Guan +6

    Мақола20132 иқтибос
    ABI
  3. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits

    Su‐Lan Hsiu, Tang-Yen Huang, Yu‐Chi Hou +2

    Мақола20022 иқтибос
    ABI
  4. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents

    Xinbing Sui, Na Kong, Li Ye +5

    Шарҳ мақола20132 иқтибос
    ABI
  5. An overview of apoptosis and the prevention of colorectal cancer

    Alastair J.M. Watson

    Шарҳ мақола20052 иқтибос
    ABI
  6. Nutraceuticals: Facts and fiction

    Juan Carlos Espı́n, María‐Teresa García‐Conesa, Francisco A. Tómas‐Barberán

    Шарҳ мақола20072 иқтибос
    ABI
  7. Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

    Véronique Baldin, Jiří Lukáš, María Jesús Marcote +2

    Мақола19932 иқтибос
    ABI
  8. Activation and signaling of the p38 MAP kinase pathway

    Tyler Zarubin, Jiahuai Han

    Шарҳ мақола20052 иқтибос
    ABI
  9. Role of Flavonoids in Oxidative Stress

    Bentham Science Publisher Nicole Cotelle

    Шарҳ мақола20012 иқтибос
    ABI
  10. Cycling to Cancer with Cyclin D1

    J. Alan Diehl

    Шарҳ мақола20022 иқтибос
    ABI
  11. Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

    Jolien Tol, Miriam Koopman, Annemieke Cats +16

    Мақола20092 иқтибос
    ABI